Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance

Objective: To determine whether pharmacist is able to guaranteecold chain maintenance of thermolabile drugs during transportusing the available information in the reception processand to compare these results with those obtained in a subsequentintervention phase, in which the manufacturing laborator...

Full description

Saved in:
Bibliographic Details
Main Authors: I. Ricote-Lobera, B. Santos-Mena, S. Fraile-Gil, B. Ortiz-Martín, F. J. Hidalgo-Correas, B. García-Díaz
Format: Article
Language:English
Published: Elsevier 2014-05-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/1123.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180678350536704
author I. Ricote-Lobera
B. Santos-Mena
S. Fraile-Gil
B. Ortiz-Martín
F. J. Hidalgo-Correas
B. García-Díaz
author_facet I. Ricote-Lobera
B. Santos-Mena
S. Fraile-Gil
B. Ortiz-Martín
F. J. Hidalgo-Correas
B. García-Díaz
author_sort I. Ricote-Lobera
collection DOAJ
description Objective: To determine whether pharmacist is able to guaranteecold chain maintenance of thermolabile drugs during transportusing the available information in the reception processand to compare these results with those obtained in a subsequentintervention phase, in which the manufacturing laboratorieswere contacted. Methods: Intervention study, prospective and comparative“before-after”. It was analyzed the storage conditions duringtransport of all thermolabile drugs received in a 400-bed hospitalfor 3 months, excluding those from clinical trials. Results: The intervention allowed to ensure cold chain maintenancein 76,5% (n = 488) of received drugs, representing anincrease of 41,8% (IC 95% 36,7-46,6%; p < 0,001) comparedwith the percentage obtained before the intervention. Conclusions: The pharmacist isn’t able to ensure the cold chainmaintenance of received thermolabile drugs without temperaturemonitoring device (64,6%). Reports requested from laboratoriesallowed to increase significantly that percentage.
format Article
id doaj-art-df4c8823e40e4d1e8072cbb13f4458c9
institution OA Journals
issn 1130-6343
2171-8695
language English
publishDate 2014-05-01
publisher Elsevier
record_format Article
series Farmacia Hospitalaria
spelling doaj-art-df4c8823e40e4d1e8072cbb13f4458c92025-08-20T02:18:04ZengElsevierFarmacia Hospitalaria1130-63432171-86952014-05-0138321121510.7399/fh.2014.38.3.1123Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenanceI. Ricote-Lobera0B. Santos-Mena1S. Fraile-Gil2B. Ortiz-Martín3F. J. Hidalgo-Correas4B. García-Díaz5Residente de Farmacia Hospitalaria. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. España.Residente de Farmacia Hospitalaria. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. España.FEA Farmacia. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. España.Residente de Farmacia Hospitalaria. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. España.FEA Farmacia. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. EspañaJefe de Servicio. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. España.Objective: To determine whether pharmacist is able to guaranteecold chain maintenance of thermolabile drugs during transportusing the available information in the reception processand to compare these results with those obtained in a subsequentintervention phase, in which the manufacturing laboratorieswere contacted. Methods: Intervention study, prospective and comparative“before-after”. It was analyzed the storage conditions duringtransport of all thermolabile drugs received in a 400-bed hospitalfor 3 months, excluding those from clinical trials. Results: The intervention allowed to ensure cold chain maintenancein 76,5% (n = 488) of received drugs, representing anincrease of 41,8% (IC 95% 36,7-46,6%; p < 0,001) comparedwith the percentage obtained before the intervention. Conclusions: The pharmacist isn’t able to ensure the cold chainmaintenance of received thermolabile drugs without temperaturemonitoring device (64,6%). Reports requested from laboratoriesallowed to increase significantly that percentage.http://www.aulamedica.es/fh/pdf/1123.pdfCold chainThermolabile drugs;Drug stabilityDrug distributionRefrigerationPharmacist interventionProtocol; Quality
spellingShingle I. Ricote-Lobera
B. Santos-Mena
S. Fraile-Gil
B. Ortiz-Martín
F. J. Hidalgo-Correas
B. García-Díaz
Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
Farmacia Hospitalaria
Cold chain
Thermolabile drugs;
Drug stability
Drug distribution
Refrigeration
Pharmacist intervention
Protocol
; Quality
title Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
title_full Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
title_fullStr Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
title_full_unstemmed Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
title_short Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
title_sort thermolabile drugs pharmacist intevention as a guarantee of cold chain maintenance
topic Cold chain
Thermolabile drugs;
Drug stability
Drug distribution
Refrigeration
Pharmacist intervention
Protocol
; Quality
url http://www.aulamedica.es/fh/pdf/1123.pdf
work_keys_str_mv AT iricotelobera thermolabiledrugspharmacistinteventionasaguaranteeofcoldchainmaintenance
AT bsantosmena thermolabiledrugspharmacistinteventionasaguaranteeofcoldchainmaintenance
AT sfrailegil thermolabiledrugspharmacistinteventionasaguaranteeofcoldchainmaintenance
AT bortizmartin thermolabiledrugspharmacistinteventionasaguaranteeofcoldchainmaintenance
AT fjhidalgocorreas thermolabiledrugspharmacistinteventionasaguaranteeofcoldchainmaintenance
AT bgarciadiaz thermolabiledrugspharmacistinteventionasaguaranteeofcoldchainmaintenance